logo

Shariah compliance overview

Not Halal

Puma Biotechnology, Inc. (PBYI) is currently classified as Not Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Puma Biotechnology, Inc.

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications.

Puma Biotechnology, Inc. (PBYI) operates in the Healthcare sector, in the Biotechnology industry.

Why it is not classified as halal: it does not pass these screens: Interest-bearing securities and assets.

Business Activity
1.76%Limit 5%Pass
Interest-bearing debt
10.23%Limit 30%Pass
Interest-bearing securities and assets
44.32%Limit 30%Fail
Dividend purification
1.76%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Puma Biotechnology, Inc. (PBYI). Current Akinda screening label: Not Halal.